The forecast for Genito Urinary System and Sex Hormones sales in Italy reflects a slight year-on-year decline from 2024 to 2026, stabilizing in 2027 and 2028. The sales per capita are expected to decrease by approximately 0.9% each year from 2024 to 2026. Compared to 2023, where the value was higher, the five-year CAGR indicates a minor decrease, reflecting a gradual decline rather than abrupt changes.

Future trends to watch for:

Emerging treatments and innovations in the genito-urinary segment that may impact sales positively.
Changes in demographic factors, such as aging population, potentially increasing demand.
Regulatory changes affecting pharmaceutical sales and prescription practices.